Insider Buying: Talphera (NASDAQ:TLPH) CFO Buys $36,450.00 in Stock

Talphera, Inc. (NASDAQ:TLPH) CFO Raffi Asadorian acquired 45,000 shares of the company’s stock in a transaction that occurred on Thursday, February 12th. The stock was purchased at an average cost of $0.81 per share, for a total transaction of $36,450.00. Following the acquisition, the chief financial officer owned 91,256 shares in the company, valued at approximately $73,917.36. This trade represents a 97.28% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link.

Talphera Stock Down 3.9%

Talphera stock opened at $0.78 on Monday. Talphera, Inc. has a 52-week low of $0.38 and a 52-week high of $1.57. The firm has a market capitalization of $36.20 million, a price-to-earnings ratio of -2.04 and a beta of 0.46. The firm has a 50-day moving average price of $1.00 and a two-hundred day moving average price of $0.99.

Wall Street Analyst Weigh In

Several research firms recently commented on TLPH. Weiss Ratings restated a “sell (d-)” rating on shares of Talphera in a research report on Wednesday, January 21st. Wall Street Zen raised Talphera to a “hold” rating in a research note on Saturday, November 1st. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $6.00.

Institutional Investors Weigh In On Talphera

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Group One Trading LLC lifted its position in Talphera by 3,224.0% in the third quarter. Group One Trading LLC now owns 30,415 shares of the company’s stock worth $27,000 after purchasing an additional 29,500 shares during the period. Virtu Financial LLC bought a new stake in shares of Talphera in the 3rd quarter worth $29,000. Persistent Asset Partners Ltd acquired a new stake in shares of Talphera in the fourth quarter valued at $42,000. Mariner LLC lifted its holdings in shares of Talphera by 132.0% in the fourth quarter. Mariner LLC now owns 58,000 shares of the company’s stock valued at $66,000 after buying an additional 33,000 shares during the period. Finally, Dauntless Investment Group LLC acquired a new position in Talphera during the third quarter worth about $89,000. Institutional investors own 37.67% of the company’s stock.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.